# FDA Inspection 1281732 - Emnar Pharma Private Limited - August 28, 2025

Source: https://www.keypedia.com/records/fda_inspections/emnar-pharma-private-limited/3af387c6-25c6-4b39-bb81-b45a49bf198b
Source feed: FDA_Inspections

> FDA Inspection 1281732 for Emnar Pharma Private Limited on August 28, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1281732
- Company Name: Emnar Pharma Private Limited
- Inspection Date: 2025-08-28
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1281732 - 2025-08-28](https://www.keypedia.com/records/fda_inspections/emnar-pharma-private-limited/c2306f11-467a-4dc0-af0f-82571770a773)
- [FDA Inspection 1097858 - 2019-06-06](https://www.keypedia.com/records/fda_inspections/emnar-pharma-private-limited/0b151a39-c729-4123-a45b-0b128891f092)

Company: https://www.keypedia.com/companies/emnar-pharma-private-limited/f85b5f8d-2802-4fae-83fb-cbfc728c2cb6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c